The Way Most Vaccine Injuries Are Handled.
Not long after widespread use of vaccines in the United States, drug makers began to be subject to increasingly successful and costly vaccine injury lawsuits. This engendered a growing concern that vital vaccine
Seyfarth Synopsis: Workplace arbitration programs continued to have a profound impact on workplace class action litigation in 2021. Such programs influenced the nature of class action litigation filed and shifted the types of claims asserted
Provides “risk factors and possible mechanism” for Beovu-related Retinal Vasculitis and Retinal Vascular Occlusion
(Posted by Tom Lamb at Drug Injury Watch)
We have finally seen the first Beovu drug label change which had been anticipated since
Seyfarth Synopsis: During 2021, COVID-19 class action litigation became more pervasive in reaching across new industries and spawning new challenges on the workplace class action front. The COVID-19 pandemic had a significant impact on all
Xeljanz Safety Alert for People Who Are (1) Older, (2) Current / Past Smokers, or (3) With Cardiovascular or Cancer Risk Factors
(Posted by Tom Lamb at Drug Injury Watch)
The drug regulatory agency Health Canada issued
Seyfarth Synopsis: With the installation of a new administration in 2021, employers saw almost immediate shifts in administrative priorities. Over the past year, the Biden Administration rolled out changes on several fronts that took shape
